HRES 305 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Expressing support for the designation of the fourth Wednesday of February as "Hypertrophic Cardiomyopathy Awareness Day".
Expressing support for the designation of the fourth Wednesday of February as ``Hypertrophic Cardiomyopathy Awareness Day''.
Summary
- Expresses support for designating the fourth Wednesday of February as "Hypertrophic Cardiomyopathy Awareness Day".
- Acknowledges the critical importance of hypertrophic cardiomyopathy awareness to cardiovascular health.
- Recognizes the need to raise public awareness of the consequences of undiagnosed and untreated hypertrophic cardiomyopathy.
- Urges Americans to seek appropriate care for hypertrophic cardiomyopathy.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
-
![Rep. LaHood, Darin [R-IL-16]](https://media.civicgate.org/people/d/politicians/L000585.thumb.jpg)
Rep. LaHood, Darin (R-IL) [#16]
Money behind the sponsor
Top reported contributors to Darin Lahood’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- SPRINGFIELD ARMORY $25,000
- Employer not reported $24,450
- MARQUIS MANAGEMENT, INC. $23,100
- BGR GROUP $14,700
- ULINE $13,200
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Darin Lahood → · Outside spending →
Actions (2)
- Apr 8, 2025 Referred to the House Committee on Energy and Commerce. · house
- Apr 8, 2025 Submitted in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE HOUSE OF REPRESENTATIVES
April 8, 2025
Mr. LaHood submitted the following resolution; which was referred to the Committee on Energy and Commerce
RESOLUTION
Expressing support for the designation of the fourth Wednesday of February as “Hypertrophic Cardiomyopathy Awareness Day”.
Whereas hypertrophic cardiomyopathy (“HCM”) is a chronic cardiac disease involving thickening of the heart muscle and can potentially lead to debilitating symptoms and serious complications including heart failure, atrial fibrillation, stroke, and in rare cases sudden cardiac death; Whereas HCM is the most common inheritable heart disease and can affect anyone regardless of age, gender, or ethnicity with a reported prevalence ranging from 1 in 200 to 1 in 500 in the general population; Whereas an estimated 700,000 to 1,650,000 people in the United States have HCM, yet 85 percent of them may remain undiagnosed; Whereas HCM shares symptoms with other common cardiovascular and pulmonary diseases, such as shortness of breath, chest pain, fatigue, palpitations, and fainting, making it difficult to distinguish HCM from these other diseases; Whereas, when untreated, all-cause mortality risk is 3 to 4 times higher in patients with HCM than that of the general population; Whereas knowing one’s medical history and any signs and symptoms of HCM is an important first step in receiving an accurate diagnosis of HCM; Whereas a health care provider must conduct thorough screening with cardiac health questions to help identify a risk of cardiac disorders, both genetic and congenital; Whereas a health care provider may conduct several tests, including an echocardiogram, a cardiac MRI, or genetic testing to confirm a family history of HCM, and must examine the heart to diagnose HCM; Whereas, following a diagnosis of HCM, it is important for patients to work with their health care provider to learn more about their disease and understand different management options, including prescription medicines and surgical treatment options that may help; and Whereas “Hypertrophic Cardiomyopathy Awareness Day” is expected to be observed in the United States for years to come, providing hope and information for patients, caregivers, and families around the country: Now, therefore, be it Resolved, That the House of Representatives—
(1) supports the designation of “Hypertrophic Cardiomyopathy Awareness Day”;
(2) acknowledges the critical importance of hypertrophic cardiomyopathy awareness to improve cardiovascular health; and
(3) recognizes the need to raise public awareness of the consequences of undiagnosed and untreated hypertrophic cardiomyopathy and urges all Americans to seek appropriate care. <all>
Comments